Book a demo
Capital & FinanceEvent: September 2, 2026

Vector Talent notes that Samsung Biologics is raising $2.18B, with $1.97B allocated to the PolyPeptide Group acquisition and $210M allocated to Bio Campus II.

Published

Signal category

Capital & Finance

Quote

Samsung Biologics is raising $2.18B. Around $1.97B of it goes to the PolyPeptide Group acquisition, with $210M into Bio Campus II.

Jack Shute|Vector Talent team

Company

Vector Talent

Driving the Future of Pharma Services Through Talent

Industry
Staffing and Recruiting
Location
Cheltenham, GB
Company size
14 employees

We work exclusively in pharma services and that focus runs deeper than a sector label. Our team has spent time on the inside of these businesses, building teams, scaling operations and navigating the pressures that come with growth in a regulated, outsourced environment. That experience shapes how we work. We know which roles are truly critical, what good looks like at different stages, and where hiring decisions tend to go wrong under pressure. We help organisations build and develop the teams that carry their most important work forward, through executive search, scalable recruitment outsourcing, and specialist training for in-house talent teams. Our clients range from fast-growing CDMOs managing rapid expansion to CROs navigating complex clinical delivery and biotechs building out their commercial and quality functions ahead of key milestones. Whatever the stage or challenge, we start by understanding the problem before we talk about the solution. We're based in the UK, with reach across the world. If you're trying to hire well in pharma services, or build a recruitment function that performs under pressure, we'd be glad to talk.

Founded 2021

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.